Skip to content
WeighLab
Menu
Ranked #7 · Grade B+

Gimme Care review

Low, fully-disclosed pricing on both molecules nationwide from a LegitScript-verified operator — strong dollar-for-dollar value.

Visit Gimme Care Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$130/mo
Tirzepatide
$163/mo
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$1,560

Tirzepatide · modeled / year

$1,956

The Index scorecard

Gimme Care scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month90/100
Price Transparency87/100
Nationwide Access96/100
Formulation Options78/100
Clinical Oversight87/100
Contract Flexibility84/100

Where the value is

  • Low published prices on both molecules — $130 semaglutide / $163 tirzepatide
  • Nationwide all-50 availability with both molecules disclosed
  • LegitScript-certified pharmacy behind the program

The tradeoffs

  • Compounded only — no brand-name or oral options
  • Lower-profile brand with a thinner public track record

The bottom line

Best for: Budget-conscious shoppers who want both molecules disclosed, nationwide access, and pharmacy verification without a premium. Low, fully-disclosed pricing on both molecules nationwide from a LegitScript-verified operator — strong dollar-for-dollar value.

Ranked #7 of 25 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've modeled, in Cost-Efficiency Index order.

Pricing, states and verification reflect Gimme Care's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Gimme Care's site. Not medical advice; see our disclosure.

← Back to the value leaderboard